rs4565713
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002506.3(NGF):c.-137+11326C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.589 in 151,996 control chromosomes in the GnomAD database, including 27,761 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.59 ( 27761 hom., cov: 32)
Consequence
NGF
NM_002506.3 intron
NM_002506.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.377
Publications
8 publications found
Genes affected
NGF (HGNC:7808): (nerve growth factor) This gene is a member of the NGF-beta family and encodes a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of this gene's expression is associated with allergic rhinitis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.691 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NGF | NM_002506.3 | c.-137+11326C>T | intron_variant | Intron 1 of 2 | ENST00000369512.3 | NP_002497.2 | ||
| NGF | NM_001437545.1 | c.-13+11326C>T | intron_variant | Intron 1 of 1 | NP_001424474.1 | |||
| NGF-AS1 | NR_157569.1 | n.208-38792G>A | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.589 AC: 89512AN: 151878Hom.: 27748 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
89512
AN:
151878
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.589 AC: 89554AN: 151996Hom.: 27761 Cov.: 32 AF XY: 0.590 AC XY: 43826AN XY: 74302 show subpopulations
GnomAD4 genome
AF:
AC:
89554
AN:
151996
Hom.:
Cov.:
32
AF XY:
AC XY:
43826
AN XY:
74302
show subpopulations
African (AFR)
AF:
AC:
17344
AN:
41410
American (AMR)
AF:
AC:
8799
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
2003
AN:
3472
East Asian (EAS)
AF:
AC:
1774
AN:
5162
South Asian (SAS)
AF:
AC:
2756
AN:
4808
European-Finnish (FIN)
AF:
AC:
7596
AN:
10574
Middle Eastern (MID)
AF:
AC:
163
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47305
AN:
67964
Other (OTH)
AF:
AC:
1246
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1762
3524
5285
7047
8809
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1590
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.